|

Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

RECRUITINGSponsored by Guangdong Provincial People's Hospital
Actively Recruiting
SponsorGuangdong Provincial People's Hospital
Started1999-01
Est. completion2025-01
Eligibility
Age16 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06554119

Summary

This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.

Eligibility

Age: 16 Years+Healthy volunteers accepted
Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery

Exclusion Criteria: age \<16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.

Conditions2

Heart DiseaseTricuspid Valve Regurgitation; Complications, Longterm Outcome

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.